XML 20 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
REVENUES $ 3,861 $ 4,128
COMPANY'S SHARE IN COLLABORATION AGREEMENT (133) 1,872
COST OF REVENUES (1,320) (778)
GROSS PROFIT 2,408 5,222
RESEARCH AND DEVELOPMENT EXPENSES (8,847) [1] (10,563) [1]
less - grants and reimbursements 2,003 2,292
RESEARCH AND DEVELOPMENT EXPENSES, NET (6,844) (8,271)
GENERAL AND ADMINISTRATIVE EXPENSES (1,629) [2] (1,989) [2]
OPERATING LOSS (6,065) (5,038)
FINANCIAL (Expenses) INCOME - NET 161 (14)
NET LOSS FOR THE PERIOD $ (5,904) $ (5,052)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED: $ 0.07 $ 0.06
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE of common stock, basic and diluted 87,821,078 81,744,547
[1] Research and development expenses include share-based compensation of $61 and $104 for the three-month periods ended March 31, 2012 and March 31, 2011, respectively.
[2] General and administrative expenses include share-based compensation of $68 and $138 for the three-month periods ended March 31, 2012 and March 31, 2011, respectively.